Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DOI

10.1111/bjh.15460

Type

Journal article

Journal

Br J Haematol

Publication Date

08/2018

Volume

182

Pages

344 - 359

Keywords

chronic lymphocytic leukaemia, management of side effects, pre-therapy assessment, supportive care, therapy, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Contraindications, Drug, Frailty, Hematopoietic Stem Cell Transplantation, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Mutation, Palliative Care, Randomized Controlled Trials as Topic, Recurrence, Tumor Suppressor Protein p53